Active Biotech AB (publ)

kr 3.60As of Sun 8 Nov 2026, 12:00 UTC
STO:ACTIHealthcare
Country Sweden
PE (Fwd) •••
TSR 10Y CAGR (33.47%)
Div yield —
ROE (215.75%)
Biotechnology
Beta (5Y) 1.44
PE TTM —
TSR TTM (41.38%)
Mkt cap kr 94.90M
ROIC (135.01%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 3.46
(3.76%)
(29.22%)
Hold 7|3|12|10|12
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.05
0.05
0.05
0.05
15.22%
10.11%
4.02%
0.93%
Revenuekr M
4.649
4.584
4.491
4.739
12.09%
9.24%
2.42%
4.70%
Peers (US$9.594M)
Cap (US$)
PE
10.99M
—
9.614M
—
Capital
TTM
5Y
10Y
Leveragex
0.166
0.692
0.642
EBIT/Intx
3.860
0.134
0.155
Own earn%
(416.17)
(112.37)
(112.22)
Sh yield%
29.00
21.64
20.46
Owners
Insiders/Inst%
2.69
51.34
Short interest%
0.84
SBC / revenue%
5.54
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
5
Op margin range%
15–20
$1 testx
0.0
Incr. ROIC%
4